Leggett & Platt EVP awarded 75 LEG shares

LEGGETT & PLATT EVP Ryan Michael Kleiboeker received an equity award of 75.5357 shares of common stock, labeled as a grant, award, or other acquisition.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

LEGGETT & PLATT EVP Ryan Michael Kleiboeker received an equity award of 75.5357 shares of common stock, labeled as a grant, award, or other acquisition. The shares were valued at $10.2255 per share, bringing his directly held common stock to 110,443.5447 shares after this award.

He also has indirect ownership positions, including 874.1340 shares held in trust under the company’s retirement plan and 1,000.0000 shares held through his spouse’s IRA, providing additional exposure to LEGGETT & PLATT stock outside his direct holdings.

Insider Trade Summary

Grant/Award: 75.5357 shares

Grant/Award 3 txns

Insider KLEIBOEKER RYAN MICHAEL

Role EVP-Chief Strategic Plan. Off.

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	75.5357	$10.2255	$772.39
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 110,443.5447 shares (Direct); Common Stock — 1,000 shares (Indirect, By Spouse's IRA); Common Stock — 874.134 shares (Indirect, Held in Trust Under Issuer's Retirement Plan)

Key Figures

Shares granted: 75.5357 shares Grant price: $10.2255 per share Direct holdings after transaction: 110,443.5447 shares +3 more

6 metrics

Shares granted 75.5357 shares Common stock grant coded as award on 2026-04-17

Grant price $10.2255 per share Value used for the 75.5357-share award

Direct holdings after transaction 110,443.5447 shares Common stock directly owned by Ryan Kleiboeker after award

Retirement plan trust holdings 874.1340 shares Indirectly held in trust under issuer’s retirement plan

Spouse IRA holdings 1,000.0000 shares Indirectly held through spouse’s IRA

Transaction date 2026-04-17 Date of reported grant and holdings update

Key Terms

Grant, award, or other acquisition, Held in Trust Under Issuer's Retirement Plan, By Spouse's IRA, indirect ownership

4 terms

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Held in Trust Under Issuer's Retirement Plan financial

"nature_of_ownership: Held in Trust Under Issuer's Retirement Plan"

By Spouse's IRA financial

"nature_of_ownership: By Spouse's IRA"

indirect ownership financial

"ownership_type: indirect for retirement plan and spouse IRA holdings"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did LEG (Leggett & Platt) EVP Ryan Kleiboeker report in this Form 4?

He reported receiving 75.5357 shares of LEG common stock as a grant or award. This increased his directly held position to 110,443.5447 shares, reflecting routine equity-based compensation rather than an open-market stock purchase or sale.

Was the LEG Form 4 transaction a buy or sell of stock?

The key transaction is coded as a grant or award, not an open-market buy or sell. Ryan Kleiboeker acquired 75.5357 shares through compensation, with the filing showing no open-market purchase or sale activity by him on the reported date.

How many LEG shares does Ryan Kleiboeker hold after this reported award?

Following the award, he directly holds 110,443.5447 LEG common shares. The filing also shows 874.1340 shares held in a retirement plan trust and 1,000.0000 shares in his spouse’s IRA, which are reported as indirect ownership positions.

What price was used for the equity award in the LEG Form 4?

The 75.5357-share grant was reported at $10.2255 per share. This per-share value is part of the Form 4 disclosure and typically reflects the fair market value used for compensation accounting purposes rather than a negotiated trade price in the open market.

Does this LEG Form 4 indicate any changes in derivative or option positions?

The filing’s derivative summary is empty, indicating no derivative securities, such as stock options or similar instruments, were reported in this particular Form 4. The disclosure focuses solely on common stock holdings and the newly awarded shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 04/20/2026 - 02:22 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KLEIBOEKER RYAN MICHAEL

(Last)

(First)

(Middle)

NO. 1 LEGGETT ROAD

(Street)

CARTHAGE

MISSOURI

64836

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LEGGETT & PLATT INC [ LEG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP-Chief Strategic Plan. Off.

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	04/17/2026		A		75.5357	A	$10.2255	110,443.5447	D
Common Stock								1,000	I	By Spouse's IRA
Common Stock								874.134	I	Held in Trust Under Issuer's Retirement Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

Remarks:

	/s/ Stanley Scott Luton, attorney-in-fact	04/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR